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Conclusions: Multi-level TDA constructs for MLDDD demonstrate favourable and sustained 
clinical outcomes at mid- to long-term follow-up.  
Key Words: artificial disc, arthroplasty, back pain, degenerative disc disease, total disc 
replacement, lumbar spine, back pain, multi-level disc arthroplasty, bisegmental, motion 
preservation.  
Level of Evidence:  4 
Key Points: 
 Multi-level lumbar disc arthroplasty surgery appears to be a suitable option for 
individuals with multi-level symptomatic degenerative disc disease refractory to 
conservative management, when appropriate diagnosis, patient selection, surgical 
technique and rehabilitation methods are followed.   
 The majority of patients showed favourable clinical outcomes at midterm follow-up.  
 92% of patients reported good to excellent satisfaction over the duration of the study. 
 The majority of patients had reduction in disability scores from severe to minimal at 
latest follow-up. 
INTRODUCTION 
‘Spinal pain’ or ‘non-specific low back pain’ are symptoms influenced by structural, 
biomechanical, biochemical, medical, psychosocial and compensable factors that can result in 
dilemmas of diagnosis and management of such complexity that treatment may be rendered 
ineffective. Distinct from ‘low back pain’, degenerative disc disease (DDD) causing 
discogenic pain is a specific diagnosis and, therefore, can be treated non-operatively or, when 
conservative care fails, operatively.1 The diagnosis is made from a combination of a clinical 
history, physical examination, radiological investigations, such as magnetic resonance 
imaging (MRI), and discriminating provocative discography with post-discography computed 
tomography scans. 2,3 Other authors have also found electrophysiological studies,4 MR 
spectroscopy 5,6 and SPECT scanning7 adjunctive in supporting a diagnosis.  
 
Basic science studies have confirmed the validity of the model of internal disc disruption 
(IDD) and the DDD cascade, which can result in discogenic pain from biomechanical, 
chemical and neural factors .2 Surgical solutions for multilevel degenerative disc disease 
(MLDDD) aim to stabilize the painful motion segments by removal of part or all of the 
sensitised discs. The benefit of the anterior lumbar approach is its ability to allow complete 
disc resection via a rectus splitting retroperitoneal approach, thus avoiding injury to the 
dynamic stabilizers. This allows the disc height and lordosis to be restored anatomically 
through parallel distraction techniques. Static or dynamic stabilization devices can be 
inserted; however, determining the best device has been associated with contentious debate 
over several decades with the options for MLDDD from an anterior approach including 
multi-level anterior lumbar interbody fusion (ALIF), hybrid fusion with lumbar total disc 
arthroplasty (TDA) surgery 8 and multi-level TDA. 9 The complexity of treating MLDDD 
with fusion techniques escalates the technical skills required of the surgeon, increases the risk 
of adverse events and produces challenges such as pseudarthrosis and adjacent motion 
segment degeneration (AMSD), rotatory instability and sagittal imbalance.10, 11 
L-TDA is now an established technology, which has clinical equipoise in reducing pain and 
improving function and a relatively reduced incidence of AMSD compared with fusion. 7,12 13 
14  Conflicting results have been reported for multi-level TDA, with reports of comparatively 
higher levels of complications, post-operative pain and inferior outcomes to single level 
TDA. 15 16 However, others have found that complications arising from multi-level TDA are 
often related to previous surgeries 17 and equivalent 18 or even superior outcomes19 have been 
reported when compared with single level TDAs. The technique of performing multilevel 
TDA requires an anterior lumbar surgery skillset, including training in retro- and trans-
peritoneal approaches, adequate skills in vessel mobilization/repair, disc clearance, 
intervertebral tension balancing and, finally, obtaining both rotatory and coronal stability. 
Progression to surgical competence in multi-level TDA generally evolves from prior mastery 
of single-level TDA techniques and where a volume-performance threshold exists.20 
 
The aim of this case series was to assess the efficacy of multi-level TDA in the treatment of 
symptomatic MLDDD through analysis of patient reported outcome measures (PROMs) and 
patient satisfaction. It is hypothesised that patients who are carefully selected and 
appropriately treated will achieve favourable outcomes over the mid- to long-term with multi-
level TDA.  
MATERIALS AND METHODS  
Patients with symptomatic MLDDD who underwent multilevel lumbar TDA between April 
1999 and January 2009 were identified and their PROMs analyzed. Patients with subsequent 
revision procedures were excluded from the analysis. This study was approved by the Bond 
University Human Research Ethics Committee (0000015881).  
All participants suffered chronic low back pain (≥12 months) and had been refractory to 
active non-operative treatment, including physical therapy and rehabilitation programs. 
Clinical indications for TDA have been demonstrated in the Food and Drug Administration 
Investigational Device Exemption (FDA IDE) studies that have published 5-year data.21,22,23 
These indications were followed, with the exception being that the primary indication was 
multi-level rather than single-level symptomatic DDD. A diagnosis of discogenic low back 
pain, with or without radicular pain, was established through clinical history, examination 
and diagnostic imaging, which included a combination of standing lumbar radiographs, MRI 
and provocative discography, with post-discography fine cut CT scan. Because of the high 
sensitivity and specificity of MRI, it remains an excellent tool for assessing disc morphology, 
but should be used in conjunction with discography when planning surgical treatment.24   The 
general principles outlined by the International Association for the Study of Pain (IASP) were 
followed when utilizing discography as an investigative tool. Patients whose discographic 
results that were non-concordant where not offered surgery.   Electrophysiological studies 
(needle electromyography and nerve conduction studies) were performed to confirm the 
presence or absence of radiculopathy, myopathies, peripheral neuropathies and degenerative 
neurological conditions. In patients with complex vascular anatomy, a CT angiogram was 
obtained. Surgery was offered to patients who had a diagnosis of discogenic pain confirmed 
without contraindications to TDA, who had exhausted non-operative modalities, and where 
the pathology was having significant effect upon their social, recreational and employment 
activities.25 
Contraindications to TDA included ≥grade II facet arthropathy25, spondylolisthesis, 
significant scoliosis (>20 degrees), active infection, tumors, severe atherosclerosis or 
anomalies of the lumbar vessels, pregnancy and diagnostic inconsistency. Obesity and 
involvement in workers’ compensation or other litigation were regarded as relative 
contraindications.  Surgery was not offered in the presence of overt psychological 
derangement or maladaptive pain behavior.  
Surgery was performed via a midline rectus split with a left or right sided retroperitoneal 
approach.  At each level, in turn, the disc space was prepared for TDA by discectomy, disc 
space distraction and annuloplasty. After appropriate trialing, the prosthesis was then inserted 
and position confirmed in the coronal and sagittal planes by fluoroscopy. The annulus was 
repaired and an anterior longitudinal ligament reconstruction with synthetic ligament 
performed to reduce segmental coronal or rotatory instability.26 Protheses used were Charité 
(DePuy Spine, Raynham, MA, USA) in 119 patients (240 levels) and InMotion (DePuy 
Spine, Raynham, MA, USA) in 3 patients (6 levels). A peri-operative physiotherapy based 
rehabilitation program was instituted routinely, which emphasized neural stretching, 
flexibility, improved dynamic stabilizer exercise tolerance, dynamic muscle strengthening 
and aerobic fitness.  
Participants were required to complete PROMs including Oswestry Disability Index (ODI), 
Roland-Morris Disability Questionnaire (RMDQ) and self-rated indication of pain using a 
Visual Analogue Score (VAS) for back (VAS-B) and leg (VAS-L) pain (0-100 point scale) 
prior to- and at regular intervals post-surgery. Patient satisfaction was also assessed with a 
four-scale written questionnaire (excellent, good, satisfactory and poor). These outcomes 
were recorded pre- and post-surgery at 3, 6 and 12 months and yearly thereafter. The PROMs 
were analyzed by a research team independent of the surgical practice. Radiographic analysis 
was also completed at each follow-up visit to confirm the movement and alignment of the 
TDA and exclude complications (eg subsidence, subluxation, heterotopic ossification & 
AMSD). Routine standing anterior/ posterior lateral and flexion/extension radiographs where 
taken at 3 months, 6 months and 12 months post operatively. Additional radiographs, CT 
scans and/or MRI scans were obtained as needed. 
Statistical analyses were performed using R Statistical Software Version 3.3.2.  The VAS-B, 
VAS-L, ODI and RMDQ at baseline (prior to surgery) and at multiple time-points from 3 to 
120 months after surgery were summarized using medians and IQRs due to skewness of the 
raw outcomes. The change scores for ODI and RMDQ approximated a normal distribution 
and are therefore reported using mean differences (95%CI) and p-values obtained from paired 
t-tests. However, most of the change from baseline scores for the VAS outcomes also 
displayed extreme skewness, which was not corrected by transformations. Hence, the median 
difference (Hodges-Lehmann estimator) and the corresponding 95% confidence intervals are 
reported, along with the p-value obtained from the sign test. Our research group chose to 
report summary measures (mean or median) according the nature of the data (symmetry of 
distribution). At times, this has been overlooked in spine research when considering pain 
reduction, specifically distribution or change in distribution of VAS scores.27,28 Given the 
nature of the current data set, the median provided the most appropriate summary statistic, 
comparable to other studies where a mean is used (assuming a symmetrical distribution), 
given that both are considered to be the typical value according to the nature of the data.  
To account for multiple comparisons of the improvements in the actual scores, the reference 
p-value of 0.05 was adjusted using Bonferroni correction. Graphical representations of 
median changes in VAS and mean differences in ODI and RMDQ were plotted along with 
95% CI and the corresponding minimum clinically important difference (MCID) for each 
outcome.29 
RESULTS 
In total, 122 patients (77 males, 45 females) operated on between April 1999 and January 
2009 were included in this study. The average age was 42 ± 8.2 years (Range 21-61) and 
mean follow-up was 7.8 years. Two patients (1.6%) received three level TDA, whilst the 
remainder of the cohort received two level TDA (98.4%). The two three-level TDAs were at 
the levels L3-4, L4-5 and L5-S1; the majority of two levels (n=110, 90.2%) were at L4-5 and 
L5-S1; the remainder (n=10, 8.2%) being at L3-4 and L4-5. A survival of 93.2% (122/131) of 
multi-level TDA constructs at final follow-up is considered satisfactory and the problems, 
surgical strategies and subsequent outcomes of the 9 cases of revision and re-operation after 
multi-level TDA will be discussed in a separate paper. 
Table 1 shows the summary statistics for the VAS outcomes for both back and leg pain. At all 
stages of follow-up, a statistically significant difference from baseline can be seen (p<0.001). 
By 12 months, the median VAS-B had improved by 88.75% to a score of 9/100.  
A total of 24 participants, comprising of 15.5% of the total sample, were lost to follow-up. 
More than half (n=14; 58.3%) of these patients reported a patient satisfaction score of 
Excellent or Good at the last recorded follow-up point which, on average, occurred at 79.7 
months (6.6 years).  The primary reason for loss to follow-up was non-compliance with 
completing questionnaires despite reminders. A total of 9 patients underwent index or 
adjacent segment revision (7.3%).   
Table 1 shows the summary statistics for VAS-B and VAS-L. At all stages, a statistically 
significant difference from baseline can be seen (p<0.001). By 12 months, the median VAS-
B scores had improved by 88.8% to a score of 9/100. 
Table 2 displays the summary statistics for both the ODI and RMDQ. Statistically 
significant improvements from baseline are seen throughout the follow-up period 
(p<0.001) in both outcome measures. The average mean difference from baseline was 31.7 
points on the ODI and 12.6 on the RMDQ.  
Figure 1AB is a graphical representation of the change scores in both VAS-B and VAS-L 
over the follow-up period. The reference line in both graphs is the MCID. VAS-B and 
VAS-L median score differences can be seen to remain above the MCID consistently 
during the follow-up period.  
 
A graphical representation of the change from baseline for both the ODI and RMDQ can be 
seen in Figure 2AB. Again, at all time points, both measures are above the MCID for that 
specific outcome measure.  
 
DISCUSSION 
The aim of this study was to evaluate the PROMs of multilevel TDA for the treatment of 
symptomatic MLDDD and the efficacy of this technique is validated where appropriate 
methods of diagnosis, patient selection and technique are followed. Clinically relevant and 
statistically significant improvements in VAS-B from baseline measures were seen at all time 
points post-operatively, as all the pre- and post-operative differences were well above the 
MCID of 12 (p<0.001).30 
Given long-term single level TDA studies have reported improvement in PROMs and low 
revision rates,31, 32 there is increasing attention in the spinal community on the benefits of 
preserving motion, which facilitates the ability of patients to ‘self-centre’, thereby 
theoretically reducing the rate of AMSD. Multilevel lumbar TDA may have benefits over 
multi-level fusion in obtaining physiological positions required for activities of daily living as 
suggested by the studies on spinopelvic parameters.33, 34 Multilevel-fusion in relative 
kyphosis (particularly in patients with type III and IV spines) can cause extensor muscle 
fatigue, persistent back and leg symptoms and increase AMSD, while multi-level fusion that 
increases lordosis (particularly with type I and II spines) can cause difficulty in the elderly 
with deep squatting positions that may be required for transferring onto chairs or toileting.   
This is currently the largest multi-TDA cohort in the literature with the longest follow-up. 
Improvements in pain are similar to or greater than those reported in other studies. It is 
difficult to define reasons for this, beyond it being a product of the strict diagnostic criteria, 
patient selection, consistent surgical techniques and a structured physical therapy program. 
Back pain (VAS-B) improved post-operatively by 83.3% on average. Tropiano35 reported an 
84% improvement in back pain at final follow-up but, notably, the follow-up time was a 
mean of 1.4 years. Bertagnoli36 also demonstrated back pain improvements of 75% at 2 years 
post-surgery. At an average of 4 years, patients in the study conducted by Trincat9 had a 60% 
improvement in their back pain. Other improvements in the order of 56.8%,10 40.8%,15 37%18 
and 39.6%37 in back pain have been reported in multi-level TDAs. A study conducted by 
Yue38 showed similar pre-operative VAS-B scores (VAS-B of 77.3); however, the 
improvements were to 31.3 at 2 years (59.5%) and 28.7 at 5 years (62.9%).38 In the current 
study, at the same time frames, back pain had improved by 89.4% and 86.9% respectively.  
The median pre-operative score for leg pain in the study was 54.5 VAS-L, which improved to 
an average of 2.6 (95.2% improvement). Although the percentage improvement was higher 
than for VAS-B, due to relatively lower baseline values for VAS-L, the absolute 
improvements were smaller (as in the Trincat et al. study) 9 and percentage reduction may be 
a better measure when comparing actual pain reduction in the two VAS outcomes. A large 
proportion of patients had little to no leg pain at baseline and were expected to experience 
little or no change at follow-up (approximately 20% of the patients scored from 0-20 VAS-L 
at baseline) and this is reflected in the lower change from baseline scores and 95% 
confidence intervals (Figure 1). However, these changes were still statistically and clinically 
significant (above MCID of 16) until 36 months.39 Single level ALIF and TDA studies 
demonstrate that VAS-L can be improved and proven radiculopathy treated, with the 
extrapolation from those results suggesting multi-level TDA can also affect VAS-L 
significantly and proportionately to VAS-B. 
The ODI improved on average 31.7 points in this study, above the 18.8 points that is 
considered to be substantial benefit in taking patients from severe to minimal disability.40, 41 
Over the period observed, the ODI score for the cohort dropped from 48 to a mean post-
operative value of 11 (77% improvement), which is greater than what has been previously 
reported. Comparative reports include improvements of 50%9, 43.2%15, 31.2%37, 56.8%19 
and 58%38. The ODI improvements in the studies by both Tropiano35 and Bertagnoli36 are 
similar to the improvements seen here with 67% and 75% improvement respectively. 
However, these studies only involved 24 months and 14 months follow-up; thus, the effect of 
PROMs decay could not be assessed. Few other long-term studies have utilised the RMDQ as 
an outcome measure and, therefore, while the data presented here is favourable (78-94% 
improvement from baseline depending on timepoint chosen) they are included for 
comparative purposes with future studies that may also utilise this outcome measure.    
Not all patients with symptomatic multiple level discogenic pain are suitable for multi-level 
TDA. Considerations for this include spinopelvic parameters, operative level, facet arthritis, 
bone density, the presence or absence of radiculopathy, and other comorbidities, as discussed 
previously. The evidence suggests that, when patients are appropriately selected, effective 
and durable results can be obtained.   
This study is a prospective case series that supports the safety and efficacy of multi-level 
TDA with a clearly defined protocol and explicit inclusion and exclusion criteria. Patients 
were enrolled consecutively and the follow-up of clinical outcomes occurs on an annual basis 
indefinitely. In addition, the follow-up rate is high; thus, the validity of the treatment effect 
and the study protocol is robust. However, it is acknowledged that a case series does not have 
a control group and can be prone to bias, thus limiting its generalisability to larger 
populations and surgeons at other institutions. An unconstrained TDA implantation at 
multiple levels is technically demanding whereas newer, more rotationally constrained, one 
piece prostheses may prove to be ‘more forgiving’ and thereby result in relatively better 
clinical and radiological outcomes for multi-level TDA.26   
The authors recognise the importance of coronal and sagittal balance.  The ability to fully 
understand global alignment and the types of spine via EOS™ has only been available 
recently, whereas the patient cohort in this study received treatment between 1999 and 2009.  
Since the advent of EOS™ imaging, much emphasis is placed on analysing the relationship 
between the pelvis and the spinopelvic parameters.  When considering multi-level TDA, 
surgeons need to consider spinopelvic parameters and the type of spine just as much as the 
type of prosthesis (constrained or unconstrained). 
Future studies should compare long-term clinical outcomes of single level TDA, multi-level 
TDA and hybrid construct surgery for the treatment of DDD.  
CONCLUSION 
This study suggests that multi-level TDA for MLDDD is associated with favourable and 
sustained clinical outcomes for the majority of patients. Provided diagnosis, patient selection, 
surgeon technique and rehabilitation are adequate, multi-level lumbar TDA is an effective 
management technique for individuals identified as being affected by more than one 
degenerative disc. To our knowledge, this represents the largest cohort and longest follow-up 
of multi-level lumbar TDA constructs in the literature. 
REFERENCES 
1. Bogduk N. Management of chronic low back pain. Med J Aust. 2004;180(2):79-83. 
2. Sehgal N, Fortin JD. Internal disc disruption and low back pain. Pain Physician. 
2000;3(2):143-157. 
3. Lee YC, Zotti MG, Osti OL. Operative Management of Lumbar Degenerative Disc 
Disease. Asian Spine J. 2016;10(4):801-819. 
4. Cho SC, Ferrante MA, Levin KH, Harmon RL, So YT. Utility of electrodiagnostic 
testing in evaluating patients with lumbosacral radiculopathy: An evidence-based 
review. Muscle Nerve. 2010;42(2):276-282. 
5. Brayda-Bruno M, Tibiletti M, Ito K, et al. Advances in the diagnosis of degenerated 
lumbar discs and their possible clinical application. Eur Spine J. 2014;23 Suppl 
3:S315-323. 
6. Zuo J, Joseph GB, Li X, et al. In-vivo Intervertebral Disc Characterization using 
Magnetic Resonance Spectroscopy and T(1ρ) Imaging: Association with Discography 
and Oswestry Disability Index and SF-36. Spine (Phila Pa 1976). 2012;37(3):214-
221. 
7. Malham GM, Parker RM, Ballok ZE, Goss B, Diwan AD, Uribe JS. Bone scans are 
reliable for the identification of lumbar disk and facet pathology. Global Spine J. 
2015;5(1):23-30. 
8. Scott-Young M, McEntee L, Schram B, Rathbone E, Hing W, Nielsen D. The 
Concurrent Use of Lumbar Total Disc Arthroplasty and Anterior Lumbar Interbody 
Fusion: The Lumbar Hybrid Procedure for the Treatment of Multi-Level Symptomatic 
Degenerative Disc Disease- A Prospective Study. Spine (Phila Pa 1976). 2017:1. 
9. Trincat S, Edgard-Rosa G, Geneste G, Marnay T. Two-level lumbar total disc 
replacement: Functional outcomes and segmental motion after 4 years. Orthop 
Traumatol Surg Res. 2015;101(1):17-21. 
10. Röllinghoff M, Schlüter-Brust K, Groos D, et al. Mid-range outcomes in 64 
consecutive cases of multilevel fusion for degenerative diseases of the lumbar spine. 
Orthop Rev (Pavia). 2010;2(1):e3. 
11. Campbell PG, Yadla S, Malone J, et al. Complications related to instrumentation in 
spine surgery: a prospective analysis. Neurosurg Focus. 2011;31(4):E10. 
12. Zigler J, Sachs B, Rashbaum R, Ohnmeiss D. Two level total disc replacement with 
Prodisc: results and comparison to one level cases. Spine J. 2005;5:S4-S5. 
13. David T. Long-term results of one-level lumbar arthroplasty: minimum 10-year 
follow-up of the CHARITE artificial disc in 106 patients. Spine (Phila Pa 1976). 
2007;32(6):661-666. 
14. Ren C, Song Y, Liu L, Xue Y. Adjacent segment degeneration and disease after 
lumbar fusion compared with motion-preserving procedures: a meta-analysis. Eur J 
Orthop Surg Traumatol. 2014;24 Suppl 1:S245-253. 
15. Siepe CJ, Mayer HM, Heinz-Leisenheimer M, Korge A. Total lumbar disc 
replacement: different results for different levels. Spine (Phila Pa 1976). 
2007;32(7):782. 
16. Siepe CJ, Heider F, Wiechert K, Hitzl W, Ishak B, Mayer MH. Mid- to long-term 
results of total lumbar disc replacement: a prospective analysis with 5- to 10-year 
follow-up. Spine J. 2014;14(8):1417. 
17. Clavel P, Ungureanu G, Catalá I, Montes G, Málaga X, Ríos M. Health-related 
quality of life in patients undergoing lumbar total disc replacement: A comparison 
with the general population. Clin Neurol Neurosurg. 2017;160:119-124. 
18. Hannibal M, Thomas DJ, Low J, Hsu KY, Zucherman J. ProDisc-L total disc 
replacement: a comparison of 1-level versus 2-level arthroplasty patients with a 
minimum 2-year follow-up. Spine (Phila Pa 1976). 2007;32(21):2322. 
19. Schätz C, Ritter-Lang K, Gössel L, Dreßler N. Comparison of Single-Level and 
Multiple-Level Outcomes of Total Disc Arthroplasty: 24-Month Results. Int J Spine 
Surg. 2015;9:14. 
20. Regan, John J, McAfee, Paul C, Blumenthal, Scott L, et al. Evaluation of Surgical 
Volume and the Early Experience With Lumbar Total Disc Replacement as Part of 
the Investigational Device Exemption Study of the Charité Artificial Disc. Spine 
2006; 31(19):2270-2276 
21. Zigler J, Gornet MF, Ferko N, et al. Comparison of Lumbar Total Disc Replacement 
With Surgical Spinal Fusion for the Treatment of Single-Level Degenerative Disc 
Disease: A Meta-Analysis of 5-Year Outcomes From Randomized Controlled Trials. 
Global Spine J. 2018 Jun;8(4):413-423. 
22.  Zigler JE, Delamarter RB. Five-year results of the prospective, randomized, 
multicenter, Food and Drug Administration investigational device exemption study of 
the ProDisc-L total disc replacement versus circumferential arthrodesis for the 
treatment of single-level degenerative disc disease. J Neurosurg Spine. 2012 
Dec;17(6):493-501 
23.  Guyer RD, McAfee PC, Banco RJ, et al. Prospective, randomized, multicenter Food 
and Drug Administration investigational device exemption study of lumbar total disc 
replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-
up. Spine J. 2009 May;9(5):374-86 
24.  Manchikanti L, Soin A, Benyamin RM, et al. An Update of the Systematic Appraisal 
of the Accuracy and Utility of Discography in Chronic Spinal Pain. Pain Physician. 
2018 Mar;21(2):91-110 
25. Weishaupt D, Zanetti M, Boos N, Hodler J. MR imaging and CT in osteoarthritis of 
the lumbar facet joints. Skeletal Radiol. 1999;28(4):215-219. 
26. Cunningham BW, Gordon JD, Dmitriev AE, Hu N, McAfee PC. Biomechanical 
evaluation of total disc replacement arthroplasty: an in vitro human cadaveric model. 
Spine (Phila Pa 1976). 2003;28(20):S110-117. 
27. Geisler FH. Surgical treatment for discogenic low-back pain: lumbar arthroplasty 
results in superior pain reduction and disability level improvement compared with 
lumbar fusion. SAS J. 2007;1(1):12-19. 
28. Ohnmeiss D. Numerical rating scales. In: Rihn JA V, AR, Albert TJ, ed. Defining the 
value of spine care. Jaypee Brothers Medical Publishers Ltd; 2012:77. 
29. Copay AG, Glassman SD, Subach BR, et al. Minimum clinically important difference 
in lumbar spine surgery patients: a choice of methods using the Oswestry Disability 
Index, Medical Outcome Study questionnaire Short Form 36, and Pain Scales. The 
Spine Journal 2008;8(6):968-974 
30. Copay AG, Eyberg B, Chung AS, et al.Minimum Clinically Important Difference: 
Current Trends in the Orthopaedic Literature, Part II: Lower Extremity: A Systematic 
Review. JBJS Rev. 2018 Sep;6(9):e2 
31. Plais N, Thevenot X, Cogniet A, Rigal J, Le Huec JC. Maverick total disc arthroplasty 
performs well at 10 years follow-up: a prospective study with HRQL and balance 
analysis. Eur Spine J. 2018;27(3):720-727. 
32. Lu SB, Hai Y, Kong C, et al. An 11-year minimum follow-up of the Charite III 
lumbar disc replacement for the treatment of symptomatic degenerative disc disease. 
Eur Spine J. 2015;24(9):2056-2064. 
33. Roussouly P, Nnadi C. Sagittal plane deformity: an overview of interpretation and 
management. Eur Spine J. 2010;19(11):1824-1836. 
34. Sparrey CJ, Bailey JF, Safaee M, et al. Etiology of lumbar lordosis and its 
pathophysiology: a review of the evolution of lumbar lordosis, and the mechanics and 
biology of lumbar degeneration. Neurosurg Focus. 2014;36(5):E1. 
35. Tropiano P, Huang RC, Girardi FP, Marnay T. Lumbar Disc Replacement: 
Preliminary Results with ProDisc II After a Minimum Follow-Up Period of 1 Year. 
Spine (Phila Pa 1976). 2003;28:362-368. 
36. Bertagnoli R, Yue JJ, Shah RV, et al. The treatment of disabling single-level lumbar 
discogenic low back pain with total disc arthroplasty utilizing the Prodisc prosthesis: a 
prospective study with 2-year minimum follow-up. Spine (Phila Pa 1976). 
2005;30(19):2230. 
37. Silvestre M, Bakaloudis G, Lolli F, Vommaro F, Parisini P. Two-level total lumbar 
disc replacement. Eur Spine J. 2009;18(Supplement 1):64-70. 
38. Yue J, Zhang K, Bai H, et al. A Comparison of Patients Who Have Undergone 1-
Level Versus 2-Level Prodisc Arthroplasty A Prospective Study With Minimum of 5-
Year Follow-up. Spine (Phila Pa 1976). 2013;38(14):1194-1198. 
39.  Copay AG, Chung AS, Eyberg B, et al. Minimum Clinically Important Difference: 
Current Trends in the Orthopaedic Literature, Part I: Upper Extremity: A Systematic 
Review. JBJS Rev. 2018 Sep;6(9):e1. 
40. Aunoble S, Meyrat R, Al Sawad Y, Tournier C, Leijssen P, Le Huec J. Hybrid 
construct for two levels disc disease in lumbar spine. Eur Spine J. 2010;19(2):290-
296. 
41. Glassman SD, Copay AG, Berven S, Polly DW, Subach BR, Carreon LY. Defining 
substantial clinical benefit following lumbar spine arthrodesis. . J Bone Joint Surg 
Am. 2010;90(9):1839-1847. 
 
Figure 
interval
 
1. Median d
s for VAS b
ifference b
ack (a) and
etween pre
 leg pain (b
- and post-
) scores in
surgery ov
 122 patien
er time, and
ts. 
 95% confidence 
 
Figure 
interval
2. Mean dif
s for ODI (
ference bet
a) and RMD
ween pre- a
Q (b) disa
nd post- su
bility score
rgery over 
s in 122 pat
time, and 9
ients 
5% confidence 
 
Table 1.  VAS back and leg pain outcomes over time in 122 patients 
VAS1 outcome Change from baseline 
Time (months) 
post-surgery 
n Median  IQR n Median 
difference2 
95% CI p-value3 
Back pain 
0  baseline 107 80.0 65.5 – 91.0     
3 85 18.0 6.0 – 33.0 79 56.0 44.3 to 62.5 <0.001 
6 93 13.0 3.0 – 26.0 85 59.0 48.0 to 67.0 <0.001 
12 101 9.0 1.0 – 26.0 88 62.0 55.3 to 66.7 <0.001 
24 96 8.5 0.8 – 25.8 82 58.0 53.6 to 65.4 <0.001 
36 96 10.5 0.0 – 31.0 82 58.5 52.6 to 65.8 <0.001 
48 86 12.5 0.0 – 28.8 73 59.0 53.6 to 66.8 <0.001 
60 78 10.5 0.0 – 35.5 68 58.0 46.8 to 66.2 <0.001 
72 89 14.0 2.0 – 32.0 76 57.5 50.0 to 65.0 <0.001 
84 73 11.0 2.0 – 49.0 62 48.0 38.0 to 65.0 <0.001 
96 71 16.0 2.5 – 48.5 61 52.0 40.3 to 62.4 <0.001 
108 61 14.0 2.0 – 53.0 51 52.0 40.0 to 65.0 <0.001 
120 58 19.0 4.3 – 53.5 47 49.0 31.8 to 67.2 <0.001 
Leg pain 
0  baseline 90 54.5 19.3 – 81.0     
3 76 3.0 0.0 – 18.0 69 36.0 19.9 to 48.1 <0.001 
6 86 3.0 0.0 – 20.5 74 35.0 27.0 to 48.9 <0.001 
12 93 2.0 0.0 – 11.0 73 36.0 28.0 to 51.0 <0.001 
24 94 2.0 0.0 –   9.0 67 39.0 23.0 to 49.0 <0.001 
36 94 3.0 0.0 – 17.0 67 35.0 18.0 to 48.0 <0.001 
48 85 1.0 0.0 – 13.0 60 28.5 13.8 to 49.5 <0.001 
60 75 2.0 0.0 – 15.0 53 31.0 12.0 to 53.1 <0.001 
72 88 4.0 0.0 – 22.0 62 30.5 17.5 to 47.2 <0.001 
84 71 3.0 0.0 – 25.0 50 31.0 15.6 to 50.9 <0.001 
96 72 3.0 0.0 – 25.8 51 28.0 19.0 to 48.0 <0.001 
108 62 3.0 0.0 – 21.5 42 29.0 14.1 to 51.9 <0.001 
120 58 2.0 0.0 – 16.0 37 33.0 15.1 to 62.9 <0.001 
 
1The Visual Analogue Scale (VAS) is scored on a 0 (no pain) to 100 (worst imaginable 
pain) scale.  
2The median difference is the Hodges-Lehmann estimator. A positive median difference 
indicates an improvement or reduction in pain score from baseline (prior to surgery). 3The 
p-value is the result of the sign test.  Significance is achieved when p<0.004 using 
Bonferroni correction, as applied to multiple comparisons within each type of pain 
outcome. All differences from baseline were statistically significant. 
 
Table 2.  ODI and RMDQ disability outcomes over time in 122 patients 
Disability outcome Change from baseline  
Time (months) post-
surgery 
n Median IQR n Mean  
difference2 
95% CI p-value3 
ODI1 
0  baseline 122 48.0 34.5 – 60.0     
3 81 16.0 10.0 – 28.0 81 26.4 22.1 to 30.7 <0.001 
6 93 12.0 4.0 – 26.0 93 30.3 26.6 to 34.0 <0.001 
12 101 8.0 0.0 – 20.0 101 35.9 32.1 to 39.6 <0.001 
24 96 8.0 2.0 – 22.5 96 35.0 30.9 to 39.1 <0.001 
36 96 7.0 0.0 – 24.0 96 36.1 32.0 to 40.2 <0.001 
48 86 10.0 0.5 – 25.5 86 34.6 30.2 to 38.9 <0.001 
60 78 9.0 0.5 – 24.0 78 32.9 28.1 to 37.6 <0.001 
72 90 10.0 2.0 – 24.0 90 30.9 26.8 to 34.9 <0.001 
84 73 10.0 0.0 – 24.0 73 33.3 28.2 to 38.3 <0.001 
96 72 11.0 2.0 – 28.8 72 29.5 24.4 to 34.6 <0.001 
108 62 12.0 0.0 – 26.0 62 29.5 23.7 to 35.4 <0.001 
120 58 15.0 2.0 – 28.3 58 25.4 19.4 to 31.3 <0.001 
RMDQ4 
0  baseline 101 18.0 13.0 – 20.0     
3 76 4.0 1.0 –   9.0 73 11.1 9.6 to 12.5 <0.001 
6 86 2.0 0.0 –   6.0 77 12.1 10.6 to 13.7 <0.001 
12 94 1.0 0.0 –   5.0 82 13.3 11.9 to 14.7 <0.001 
24 94 1.0 0.0 –   5.0 77 13.1 11.7 to 14.4 <0.001 
36 95 1.0 0.0 –   5.0 77 13.6 12.2 to 15.0 <0.001 
48 86 1.0 0.0 –   5.8 71 12.9 11.5 to 14.4 <0.001 
60 78 1.0 0.0 –   6.0 63 13.2 11.7 to 14.7 <0.001 
72 90 1.0 0.0 –   6.0 72 12.3 10.7 to 13.8 <0.001 
84 73 1.0 0.0 –   7.0 60 13.2 11.6 to 14.8 <0.001 
96 72 1.0 0.0 – 10.3 58 12.0 10.1 to 14.0 <0.001 
108 62 1.0 0.0 –   6.0 51 13.1 11.3 to 15.0 <0.001 
120 58 1.5 0.0 –   6.0 51 11.5 9.5 to 13.4 <0.001 
        
 
1The Oswestry Disability Index (ODI) is scored on a 0 (none) to 100 (worst) disability. 2A 
positive mean difference indicates an improvement or reduction in disability index from 
baseline (prior to surgery).  
3The p-value is the result of the paired t-test.  Significance is achieved when p<0.004 using 
Bonferroni correction, as applied to multiple comparisons within each disability measure. All 
differences from baseline were statistically significant. 4The Roland-Morris Disability 
Questionnaire (RMDQ) is scored on a 0 (none) to 24 (worst) disability. 
